Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection.

Storkebaum E, Lambrechts D, Carmeliet P.

Bioessays. 2004 Sep;26(9):943-54. Review.

PMID:
15351965
2.

VEGF at the neurovascular interface: therapeutic implications for motor neuron disease.

Lambrechts D, Carmeliet P.

Biochim Biophys Acta. 2006 Nov-Dec;1762(11-12):1109-21. Epub 2006 May 9. Review.

3.

VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death.

Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, Desmet F, Marklund SL, Wyns S, Thijs V, Andersson J, van Marion I, Al-Chalabi A, Bornes S, Musson R, Hansen V, Beckman L, Adolfsson R, Pall HS, Prats H, Vermeire S, Rutgeerts P, Katayama S, Awata T, Leigh N, Lang-Lazdunski L, Dewerchin M, Shaw C, Moons L, Vlietinck R, Morrison KE, Robberecht W, Van Broeckhoven C, Collen D, Andersen PM, Carmeliet P.

Nat Genet. 2003 Aug;34(4):383-94.

PMID:
12847526
4.

Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model.

Corti S, Locatelli F, Papadimitriou D, Del Bo R, Nizzardo M, Nardini M, Donadoni C, Salani S, Fortunato F, Strazzer S, Bresolin N, Comi GP.

Brain. 2007 May;130(Pt 5):1289-305. Epub 2007 Apr 17.

5.

Effects of vascular endothelial growth factor (VEGF) on motor neuron degeneration.

Van Den Bosch L, Storkebaum E, Vleminckx V, Moons L, Vanopdenbosch L, Scheveneels W, Carmeliet P, Robberecht W.

Neurobiol Dis. 2004 Oct;17(1):21-8.

PMID:
15350962
6.

VEGF: necessary to prevent motoneuron degeneration, sufficient to treat ALS?

Lambrechts D, Storkebaum E, Carmeliet P.

Trends Mol Med. 2004 Jun;10(6):275-82. Review.

PMID:
15177192
7.

[VEGF as an angiogenic, neurotrophic, and neuroprotective factor].

Namiecińska M, Marciniak K, Nowak JZ.

Postepy Hig Med Dosw (Online). 2005;59:573-83. Review. Polish.

8.

Vascular endothelial growth factor in amyotrophic lateral sclerosis and other neurodegenerative diseases.

Bogaert E, Van Damme P, Van Den Bosch L, Robberecht W.

Muscle Nerve. 2006 Oct;34(4):391-405. Review.

PMID:
16856151
10.

VEGF: a critical player in neurodegeneration.

Storkebaum E, Carmeliet P.

J Clin Invest. 2004 Jan;113(1):14-8. Review.

11.

Vascular endothelial growth factor protects spinal cord motoneurons against glutamate-induced excitotoxicity via phosphatidylinositol 3-kinase.

Tolosa L, Mir M, Asensio VJ, Olmos G, Lladó J.

J Neurochem. 2008 May;105(4):1080-90. doi: 10.1111/j.1471-4159.2007.05206.x. Epub 2007 Dec 25.

12.

Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration.

Poesen K, Lambrechts D, Van Damme P, Dhondt J, Bender F, Frank N, Bogaert E, Claes B, Heylen L, Verheyen A, Raes K, Tjwa M, Eriksson U, Shibuya M, Nuydens R, Van Den Bosch L, Meert T, D'Hooge R, Sendtner M, Robberecht W, Carmeliet P.

J Neurosci. 2008 Oct 15;28(42):10451-9. doi: 10.1523/JNEUROSCI.1092-08.2008.

13.

VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.

Roscoe WA, Welsh ME, Carter DE, Karlik SJ.

J Neuroimmunol. 2009 Apr 30;209(1-2):6-15. doi: 10.1016/j.jneuroim.2009.01.009. Epub 2009 Feb 23.

PMID:
19233483
15.
16.

VEGF-overexpressing transgenic mice show enhanced post-ischemic neurogenesis and neuromigration.

Wang Y, Jin K, Mao XO, Xie L, Banwait S, Marti HH, Greenberg DA.

J Neurosci Res. 2007 Mar;85(4):740-7.

PMID:
17243175
17.

Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.

Stalmans I.

Verh K Acad Geneeskd Belg. 2005;67(4):229-76. Review.

PMID:
16334858
18.

Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS.

Storkebaum E, Lambrechts D, Dewerchin M, Moreno-Murciano MP, Appelmans S, Oh H, Van Damme P, Rutten B, Man WY, De Mol M, Wyns S, Manka D, Vermeulen K, Van Den Bosch L, Mertens N, Schmitz C, Robberecht W, Conway EM, Collen D, Moons L, Carmeliet P.

Nat Neurosci. 2005 Jan;8(1):85-92. Epub 2004 Nov 28.

19.

[Recent advance in experimental study of cerebral ischemia treated by vascular endothelial growth factor].

Li SF, Wang RZ, Li GL.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2005 Feb;27(1):115-9. Review. Chinese.

PMID:
15782506
20.

Telomerase mediates vascular endothelial growth factor-dependent responsiveness in a rat model of hind limb ischemia.

Zaccagnini G, Gaetano C, Della Pietra L, Nanni S, Grasselli A, Mangoni A, Benvenuto R, Fabrizi M, Truffa S, Germani A, Moretti F, Pontecorvi A, Sacchi A, Bacchetti S, Capogrossi MC, Farsetti A.

J Biol Chem. 2005 Apr 15;280(15):14790-8. Epub 2005 Feb 1.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk